Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Red Mountain Compounding Pharmacy is recalling S-TEST CYP 125mg/ml vials due to a lack of assurance of sterility.
Red Mountain Compounding Pharmacy is recalling S-Hydroxocobalamin 10mg/mL injection vials because there is a lack of assurance of sterility.
Red Mountain Compounding Pharmacy is recalling S-E2/Test Cyp 1mg/4mg sesame oil injections due to a lack of assurance of sterility.
Dr. Reddy's Laboratories is recalling Ranitidine Tablets 150 mg because the presence of the NDMA impurity was detected in the product.
Red Mountain Compounding Pharmacy is recalling S-TRIMIX injection vials because the product lacks assurance of sterility.
Dr. Reddy's Laboratories is recalling Ranitidine Tablets 150 mg because the presence of the NDMA impurity was detected in the product.
Red Mountain Compounding Pharmacy is recalling benzalkonium chloride solution because the product lacks assurance of sterility.
Red Mountain Compounding Pharmacy is recalling S-Glutathione 200mg/3ml inhalation solution due to a lack of assurance of sterility.
Red Mountain Compounding Pharmacy is recalling S-Sodium Selenite 0.219% injections because the agency could not ensure the product was sterile.
Red Mountain Compounding Pharmacy is recalling S-TEST CYP 200mg/ml vials nationwide due to a lack of assurance of sterility.
Red Mountain Compounding Pharmacy is recalling S-Atropine 0.02% ophthalmic solution due to a lack of assurance of sterility. The affected product is a prescription eye drop distributed nationwide.
Red Mountain Compounding Pharmacy is recalling specific lots of Testosterone Cypionate 100mg/mL in sesame oil due to a lack of assurance of sterility.
Red Mountain Compounding Pharmacy is recalling S-Procaine HCL 2% Buffered due to a lack of assurance of sterility. The affected prescription products were distributed nationwide.
Basic Reset Inc. is recalling 554 bottles of CBD Reset 750 oil because the product was marketed without an approved FDA application.
Basic Reset Inc. is recalling Miracle Facelift Masque because it was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).
Basic Reset Inc. is recalling 1,000 bottles of Nuovi Skin Toner because the product was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).
Basic Reset Inc. is recalling 949 bottles of Earth Wash Cleaner because the product was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).
Basic Reset Inc. is recalling 339 bottles of Nuovi Firming Masque because the product was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).
Basic Reset Inc. is recalling Biogenyx CBD Oil because it was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).
Basic Reset Inc. is recalling 598 bottles of CBD Reset 750 True Full Spectrum Cinnamon because the product was marketed without an approved NDA or ANDA.
Basic Reset Inc. is recalling 98 bottles of CBD Reset 750 because the product was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).
Basic Reset Inc. is recalling 391 bottles of CBD Reset 2400 because the product was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).
Basic Reset Inc. is recalling Biogenyx CBD Oil because it was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).
Lupin Pharmaceuticals is recalling specific lots of Cefdinir for Oral Suspension because a dead ant was found in the product.
Sato Pharmaceutical Inc. is recalling Sankaijo Botanical Laxative tablets because the sennosides content is lower than the labeled claim.